Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will host a virtual key opinion leader (KOL) investor event on Monday, December 8, 2025 at 10:30 AM ET. To register, click here.

Flow(TM) Voiding Prosthesis, following the Centers for Medicare & Medicaid Services (CMS) decision to establish national pricing for the CPT(R) codes related to physician procedures for the device.

Parkinson’s Disease Causes, Symptoms, and Treatment Parkinson’s disease (PD) is one of the fastest-growing neurological ...

Vesiflo, Inc. today announced a major reimbursement milestone for its inFlow™ Voiding Prosthesis, following the Centers for Medicare & Medicaid Services (CMS) decision to establish national pricing ...

Novartis plans to upfit a 202,000-square-foot purpose-built space in Pathway Triangle, a new advanced manufacturing campus in ...

Article Summary – In 2005, Swedish AIP submarine HMS Gotland stunned the U.S. Navy by repeatedly “killing” carrier USS Ronald ...

Detailed price information for Taysha Gene Therapies Inc (TSHA-Q) from The Globe and Mail including charting and trades.

Despite the recent approval of targeted biologics that can significantly improve quality of life, Canadians living with ...

Neuropsychologist Dr. Digby Orman-Brown offers a multi-domain holistic treatment to help patients dealing with dementia and ...

Chennai: A new AI-enabled deep brain stimulation (DBS) device, one that can read brain signals and adjust itself, will be ...

Rare diseases reveal that our sense of identity rests on fragile biological infrastructure, much of it operating outside ...

This valuable work provides new insights into the role of lysine acetylation of alpha-synuclein, the protein involved in Parkinson's Disease. The evidence is mostly solid, but the claims around the ...